REQUEST A DEMO
Total
USD $0.00
Search more companies

Ngenebio Co., Ltd. (South Korea)

Main Activities: Other Professional, Scientific, and Technical Services
Full name: Ngenebio Co., Ltd. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

The Company is a Korea-based company engaged in the manufacture and sale of precision diagnostic products. The Company s main products include BRCAaccuTest products used for hereditary breast and ovarian cancer testing, HEMEaccuTest products that tests the causative genes related to blood cancer such as leukemia, lymphoma, and bone marrow cancer, SOLIDaccuTest products that test the causative genes of solid cancer tissues such as lung cancer, colon cancer and stomach cancer. In addition, the Company manufactures and sells products of HLAaccuTest products that tests tissue-specific antigens used for bone marrow transplantation, ONCOaccuPanel products for precise diagnosis of large-capacity solid cancer, HEREDaccuTest products for precise diagnosis for rare diseases. The Company also provides services such as genetic testing direct to customer(DTC) and personalized healthcare. The Company was established on October 30, 2015. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on December 10, 2020.

Headquarters
303-307, 314Ho, 288, Digital-Ro, Guro-Gu
Seoul; Seoul;

Contact Details: Purchase the Ngenebio Co., Ltd. report to view the information.

Website: http://ngenebio.com

Basic Information
Total Employees:
Purchase the Ngenebio Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Ngenebio Co., Ltd. report to view the information.
Registered Capital:
Purchase the Ngenebio Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Ngenebio Co., Ltd. report to view the information.
Incorporation Date:
October 30, 2015
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Auditor
Company Performance
Financial values in the chart are available after Ngenebio Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
53.81%
Total operating revenue
49.12%
Operating profit (EBIT)
-1.24%
EBITDA
2.05%
Net Profit (Loss) for the Period
-16.7%
Total assets
28.03%
Total equity
-25.5%
Operating Profit Margin (ROS)
40.7%
Net Profit Margin
28.39%
Return on Equity (ROE)
-14.05%
Debt to Equity Ratio
24.03%
Quick Ratio
-1.86%
Cash Ratio
-1.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?